Risky Business: The far-reaching consequences of slashing the orphan drug tax credit

by Christopher Gerry The routes that lead to a career in biomedicine are as diverse as they are plentiful, but one of my colleagues has taken a particularly unorthodox path. Sonia had just graduated from law school when she learned of a “typo” in her genetic code that will almost certainly induce a fatal and untreatable brain disorder called prion disease. She and her husband, … Continue reading Risky Business: The far-reaching consequences of slashing the orphan drug tax credit